Skip to main content

Health and Medicine

Fungus toxin gets in the way in DNA

Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.

Read more


Heart protein may be target for colon cancer therapies

Oct. 7, 2011—A protein critical in heart development may also play a part in colon cancer progression.

Read more


Parkinson’s deep brain target fired up

Oct. 5, 2011—Neuronal activity in a deep brain region increases as Parkinson’s disease advances, a new study suggests.

Read more


Drug-like molecules aimed at improving treatment of Parkinson’s

Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.

Read more


Folate may lower breast cancer risk for some

Sep. 29, 2011—Low folate levels may increase a premenopausal woman’s risk of developing breast cancer.

Read more


Study puts a new spin on ibuprofen’s actions

Sep. 29, 2011—Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs.

Read more


New study confirms safety of eight vaccines

Sep. 28, 2011—A report released by the Institute of Medicine confirms the safety of eight vaccines studied by a committee of experts. Evidence showed no links between immunization and serious conditions that have raised concerns, including Type 1 diabetes and autism.

Read more


Examining the ethics of sharing genetic risk information

Sep. 28, 2011—Should scientists inform participants in genomic studies about their risk for diseases or conditions discovered during the studies, and if so, when and how? A Vanderbilt professor is part of a team working to answer these questions.

Read more


Interactive brain exhibit opens at Vanderbilt Health One Hundred Oaks

Sep. 27, 2011—A state-of-the-art interactive exhibit on the brain and brain research has opened at Vanderbilt Health One Hundred Oaks.

Read more


New drug-like molecules could improve schizophrenia treatment

Sep. 22, 2011—The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia.

Read more


‘Toolkit’ makes medical procedures less stressful for children with autism

Sep. 21, 2011—Resource for physicians and parents created to make routine medical procedures less stressful for children with autism.

Read more


Milestone in development of new treatment for ‘fragile X’

Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.

Read more